Skip to content

Clinical trials

Phase 4 Hypercholesterolemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 4 Clear all

147 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20027
200312
20046
200518
20065
20079
200813
20099
20108
20119
20123
20134
20142
20154
20165
20177
20186
20191
20203
20212
20221
20231
20242
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109
Unknown status17
Terminated9
Recruiting4
Withdrawn4
Not yet recruiting2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Organon and Co18
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.8
Daiichi Sankyo6
AstraZeneca5
Gachon University Gil Medical Center5
Duke University3
JW Pharmaceutical3
Novartis Pharmaceuticals3
Seoul National University Hospital3
Yonsei University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia147
Atherosclerosis16
Cardiovascular Diseases13
Dyslipidemias12
Coronary Artery Disease11
Hyperlipidemias10
Coronary Disease8
Diabetes Mellitus, Type 28
Hypertension8
Diabetes Mellitus7

Trials

Showing 1 to 25 of 147. Each trial links to its page on Pharma Observatory.

47 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.